As our #ASH21 blog comes to a close, the hematology community has much to look forward to with a plethora of clinically relevant data, emerging novel therapies, a better understanding of mechanisms of resistance that can lead to new therapeutic strategies, and a strong commitment from the leading hematology organization to address disparities and ensure equity. Read More

Day 3 of the ASH Annual Meeting & Exposition kicked off with a continuation of the Diversity, Health, and Equity track, focusing on changing the tide from paternalistic patterns and exclusion of marginalized populations to inclusion of clinical trial design and a “deliberateness” of engaging minority communities from the very start. This important effort to reevaluate the status quo is part of the hematology community’s commitment to ensuring equity and addressing disparities. Read More

Read a short recap of insights about day 2 of ASH, the world’s largest professional society committed to conquering blood diseases, ASH. Read More

The first day of the highly anticipated 63rd ASH Annual Meeting & Exposition kicked off with a new track focused on diversity, health, and equity. As the world’s largest professional society committed to conquering blood diseases, ASH is building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences.  Read More

As patients take an increasingly active role in their own care, education plays a central role. Knowledge fosters shared decision making among providers, patients, and their families. We're pleased to Read More

Tracking outcomes is essential to PlatformQ Health education, both as a means to continually enhance engagement and to assess knowledge gaps that support the development of future programming. We're pleased Read More

Education is at the heart of everything -- from launching new screening protocols, to releasing new medications, to enhancing patients’ quality of life.  Read More

Tethered education: Aligning patients and providers  What spurs patients to choose one treatment option over another? What are the hurdles patients face when presented with a newly FDA approved drug? Read More

Clinicians are facing challenges with diagnosing a wide range of conditions. Read More

After the CME session, 74 percent of learners reported that the activity positively impacted their clinical practice while 61 percent of learners reported that the activity positively impacted patient experiences and outcomes. Read More

Through tethered education PlatformQ Health sought to address educational gaps around understanding treatment options, side effects, side of disability progression, and strategies to manage functional losses. Read More

PlatformQ Health teamed up with Advances in Neuroblastoma Research Association and Solving Kids' Cancer to develop two one-hour CME programs for clinicians, patients, and caregivers. Read More